Henry Ford Health performs first K-Clip procedure in the U.S. to treat severe tricuspid regurgitation

A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease recently became the first in the United States and the Western Hemisphere to repair a heart valve with severe tricuspid regurgitation in a patient using the investigational K-Clip™ Transvascular Tricuspid Repair System.

Biotech’s IPO outlook for the rest of the year sours in wake of war, broader industry struggles

Forget IPOs. Biotech insiders expect to see a handful of reverse mergers before the end of the year, similar to Wednesday’s handshake between Nasdaq-listed Graphite

November 17, 2023

FDA makes it easier for biosimilars to obtain interchangeability designations

The FDA on Thursday began easing the process for biosimilar developers to demonstrate interchangeability with their brand-name biologics. The agency previously required studies to prove

June 21, 2024

Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn – Pharmaceutical Technology

Eli Lilly (Indianapolis, IN, US) and Novo Nordisk (Bagsvaerd, Denmark) have announced that the supply of their GLP-1 weight loss drugs has improved, with the

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.